Aesthetics attended the launch of skincare company Medik8’s new Exo-PDRN Prismatic+ Pro Concentrate.
Hosted at the Frameless Immersive Art Experience, the event introduced Medik8’s latest launch, available through aesthetic distributor Healthxchange. Dan Isaacs, co-founder and chief product officer of Medik8, shared that the Exo-PDRN Prismatic+ Pro Concentrate is designed to enhance in-clinic results after treatments such as microneedling, chemical peels, laser treatment and as general aftercare. Isaacs also outlined the key ingredients including Prismatic Polydeoxyribonucleotide, Triple Exosome Complex,
Dual MiniProtein, adenosine triphosphate precursor and amino acids. Following this, a panel discussion took place, chaired by Simone Shoffman, clinical and education director at Healthxchange, featuring aesthetic practitioners Dr Sophie Shotter, Dr Bibi Ghalaie and Dr Tara Francis, along with independent nurse prescriber Nina Prisk.
The panel discussed how they use the product in clinic and presented individual case studies.
Shoffman commented, “Medik8’s Exo-PDRN Prismatic+ Pro Concentrate is setting a new benchmark for in-clinic rejuvenation. Designed exclusively for skincare professionals, it delivers bioengineered vegan PDRN in a concentrated formula, giving practitioners a powerful tool to address the growing patient demand for targeted, longevity-focused outcomes that go beyond a core routine.”